![](/rp/kFAqShRrnkQMbH6NYLBYoJ3lq9s.png)
Know Your Ports - Oncology Nursing News
Dec 21, 2017 · Throughout the course of treatment, many patients with cancer receive chemotherapy, intravenous fluids, antibiotics, and much more via central venous catheters …
How ctDNA Testing Is Being Used To Diagnose And Monitor Cancer
Dec 18, 2024 · “ctDNA testing looks for small pieces of DNA found in a patient’s blood that comes from cancer cells and tumors,” Grafton explains. “Screening for ctDNA can be used to detect …
Oncology Nursing News
Dr Mohan engages with Nurse Goff, Dr Mann, and Nurse Brigle to explore effective multidisciplinary approaches for managing adverse events (AEs) associated with bispecific …
Evaluating Targeted Therapies: MARIPOSA Trial Aids APPs in …
Jan 3, 2025 · As the treatment landscape continues to evolve in non-small cell lung cancer (NSCLC), understanding options for those with advanced, treatment-naïve EGFR-positive …
ASCO Recommends Abemaciclib for High-Risk HR+, HER2- Breast …
Oct 24, 2024 · The American Society of Clinical Oncology (ASCO) recently announced guidelines outlining a preference for abemaciclib (Verzenio) over ribociclib (Kisqali) for the treatment of …
20 Inspirational Quotes for Cancer Survivors, Fighters, and Caregivers
Aug 25, 2015 · Keeping a positive outlook is proven to help with stress management, but when someone says to "think positive" or "be optimistic" during a time such as cancer, it can be …
Belantamab Mafodotin, KRd Is Promising in Relapsed/Refractory …
Oct 2, 2024 · Belantamab mafodotin-blmf (Blenrep) plus carfilzomib, lenalidomide (Revlimid), and dexamethasone (a regimen known as KRd) demonstrated early evidence of deep responses, …
PD-L1 CPS Score Could Direct Treatment Decisions in Recurrent ...
Apr 1, 2022 · PD-L1 combined positive score (CPS) may serve to predict whether a patient with PD-L1–expressing recurrent or metastatic head and neck squamous cell carcinoma (HNSCC) …
Opinion: The Media May Have Oversold AOH1996, City of Hope's …
Sep 20, 2023 · Early-phase clinical trials often involve medications that have not yet received their official names. Typically, these innovative drugs are given temporary names made up of a …
Advancing Multiple Myeloma Treatment With CAR T-Cell Therapy
Jul 10, 2024 · CAR T-cell therapy represents a significant advancement in the treatment of multiple myeloma, especially as its ability to provide deep and durable responses offers …